259 related articles for article (PubMed ID: 20864675)
1. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
Wu J; Echeverry R; Guzman J; Yepes M
Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
[TBL] [Abstract][Full Text] [Related]
2. Neuroserpin, a neuroprotective factor in focal ischemic stroke.
Cinelli P; Madani R; Tsuzuki N; Vallet P; Arras M; Zhao CN; Osterwalder T; Rülicke T; Sonderegger P
Mol Cell Neurosci; 2001 Nov; 18(5):443-57. PubMed ID: 11922137
[TBL] [Abstract][Full Text] [Related]
3. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.
Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA
J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
[TBL] [Abstract][Full Text] [Related]
5. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.
Yepes M; Sandkvist M; Wong MK; Coleman TA; Smith E; Cohan SL; Lawrence DA
Blood; 2000 Jul; 96(2):569-76. PubMed ID: 10887120
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system?
Yepes M; Lawrence DA
Trends Cardiovasc Med; 2004 Jul; 14(5):173-80. PubMed ID: 15261888
[TBL] [Abstract][Full Text] [Related]
8. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.
Lebeurrier N; Liot G; Lopez-Atalaya JP; Orset C; Fernandez-Monreal M; Sonderegger P; Ali C; Vivien D
Mol Cell Neurosci; 2005 Dec; 30(4):552-8. PubMed ID: 16209928
[TBL] [Abstract][Full Text] [Related]
9. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system.
Yepes M; Lawrence DA
Thromb Haemost; 2004 Mar; 91(3):457-64. PubMed ID: 14983220
[TBL] [Abstract][Full Text] [Related]
10. Effect of neuroserpin in a neonatal hypoxic-ischemic injury model ex vivo.
Ma J; Yu D; Tong Y; Mao M
Biol Res; 2012; 45(4):357-62. PubMed ID: 23558991
[TBL] [Abstract][Full Text] [Related]
11. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.
Osterwalder T; Cinelli P; Baici A; Pennella A; Krueger SR; Schrimpf SP; Meins M; Sonderegger P
J Biol Chem; 1998 Jan; 273(4):2312-21. PubMed ID: 9442076
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia.
Docagne F; Nicole O; Marti HH; MacKenzie ET; Buisson A; Vivien D
FASEB J; 1999 Aug; 13(11):1315-24. PubMed ID: 10428756
[TBL] [Abstract][Full Text] [Related]
13. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.
Yepes M; Lawrence DA
Exp Biol Med (Maywood); 2004 Dec; 229(11):1097-104. PubMed ID: 15564435
[TBL] [Abstract][Full Text] [Related]
14. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival.
Hastings GA; Coleman TA; Haudenschild CC; Stefansson S; Smith EP; Barthlow R; Cherry S; Sandkvist M; Lawrence DA
J Biol Chem; 1997 Dec; 272(52):33062-7. PubMed ID: 9407089
[TBL] [Abstract][Full Text] [Related]
15. Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.
Hill RM; Parmar PK; Coates LC; Mezey E; Pearson JF; Birch NP
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):595-601. PubMed ID: 10642518
[TBL] [Abstract][Full Text] [Related]
16. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome.
Rodríguez-González R; Millán M; Sobrino T; Miranda E; Brea D; de la Ossa NP; Blanco M; Perez J; Dorado L; Castellanos M; Lomas DA; Moro MA; Dávalos A; Castillo J
Thromb Haemost; 2011 Mar; 105(3):421-9. PubMed ID: 21174006
[TBL] [Abstract][Full Text] [Related]
17. Detection of truncated isoforms of human neuroserpin lacking the reactive center loop: Implications in noninhibitory role.
Fatima S; Ansari S; Bano S; Ahamad S; Ishqi HM; Tabish M; Gupta D; Rehman SU; Jairajpuri MA
IUBMB Life; 2021 Jul; 73(7):941-952. PubMed ID: 33893722
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation.
Gelderblom M; Neumann M; Ludewig P; Bernreuther C; Krasemann S; Arunachalam P; Gerloff C; Glatzel M; Magnus T
PLoS One; 2013; 8(5):e63118. PubMed ID: 23658802
[TBL] [Abstract][Full Text] [Related]
19. Neuronal depolarization enhances the transcription of the neuronal serine protease inhibitor neuroserpin.
Berger P; Kozlov SV; Cinelli P; Krüger SR; Vogt L; Sonderegger P
Mol Cell Neurosci; 1999 Dec; 14(6):455-67. PubMed ID: 10656253
[TBL] [Abstract][Full Text] [Related]
20. Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats.
Liang W; Chuan-Zhen L; Qiang D; Jian Q; Hui-Min R; Bao-Guo X
Brain Res; 2004 Jul; 1015(1-2):175-80. PubMed ID: 15223382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
